Veradermics MANE
NYSE MANE
$127.10 +4.82 (+3.94%)
As of: Oct 20, 2026 · 3:59 PM EDT

Veradermics (MANE) Current Assets (2024 - 2026)

Updated

Veradermics (MANE) posted Current Assets of $824.75 million for Q2 2026, up 107.7% from the prior quarter.

Analysis

Veradermics (MANE) Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Veradermics' Current Assets came in at $152.49 million, up 174.6% from FY2024.

  • In prior years, Veradermics' Current Assets was $55.54 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 64.67 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 59.77 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 33.67 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 36.68 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 27.35 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 27.97 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 34.96 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 13.95 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 41.36 Bn
10 Veradermics 5.17 Bn 3.77 Bn - 824.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 824.75 Mn
Mar 31, 2026 397.07 Mn
Dec 31, 2025 152.49 Mn
Dec 31, 2024 55.54 Mn
API Access

Veradermics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=MANE&period=max&api_key=YOUR_API_KEY